NeoGenomics (NEO) Tops Q2 EPS by 1c

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $67.7 million versus the consensus estimate of $66.18 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Palo Alto Networks (PANW) Tops Q3 EPS by 6c, Offers Guidance
• Medtronic (MDT) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY27 EPS Guidance